ALS Geochemistry Business Volumes Deteriorating, But Life Sciences Unit Remains Resilient, Says Jarden Research

MT Newswires Live09-23

Australian environmental testing, laboratory services, and scientific solutions company ALS (ASX:ALQ) highlighted deteriorating volumes in its geochemistry business and higher net interest costs in its fiscal first-half trading update, but its life sciences segment continues to be resilient, according to a Sept. 19 note from Jarden Research.

Commodities should adjust to further volume volatility as geochemistry sampling has been volatile during the period as Australian volumes fell 10% on already weak conditions, the investment firm said. Jarden expects the company to address this in its cost base and boost hub utilization from fiscal 2025 to fiscal 2027.

Jarden kept its overweight rating on ALS and reduced its price target to AU$14.20 from AU$14.90.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment